PRPS2 and B-cell non-Hodgkin lymphoma: Depletion of PRPS2 levels by siRNA in c-MYC-driven B-cell lymphomas improved survival and induced complete tumor regression in 30 % of mice, strongly indicating that protein and nucleotide biosynthesis controlled by PRPS2 is crucial for c-MYC-driven tumorigenesis [414].